The National Echocardiography Database Australia (NEDA) is a new echocardiography database collecting digital measurements on both a retrospective and prospective basis. To date, echocardiographic data from 435,133 individuals (aged 61.6 ± 17.9 years) with linkage to 59,725 all-cause deaths during a median of 40 months follow-up have been collected. These data will inform a number of initial analyses focusing on pulmonary hypertension, aortic stenosis and the role of artificial intelligence to facilitate accurate diagnoses of cardiac abnormalities.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2018.07.001DOI Listing

Publication Analysis

Top Keywords

echocardiography database
12
national echocardiography
8
database australia
8
australia neda
8
neda rationale
4
rationale methodology
4
methodology national
4
neda echocardiography
4
database collecting
4
collecting digital
4

Similar Publications

Background: Few studies have incorporated echocardiography and laboratory data to predict clinical outcomes in heart failure with preserved ejection fraction (HFpEF).

Objectives: This study aimed to use machine learning to find predictors of heart failure (HF) hospitalization and cardiovascular (CV) death in HFpEF.

Methods: From the Chang Gung Research Database in Taiwan, 6,092 HFpEF patients (2,898 derivation, 3,194 validation) identified between 2008 and 2017 were followed until 2019.

View Article and Find Full Text PDF
Article Synopsis
  • Left ventricular hypertrophy (LVH) is linked to serious cardiovascular issues, and identifying its cause is important for treatment; this systematic review explores how AI can help in diagnosing LVH and its causes from imaging data.
  • A thorough search was conducted utilizing multiple databases, leading to the inclusion of 30 studies which mainly focused on echocardiography and cardiac magnetic resonance imaging (CMR), with a smaller number on cardiac computed tomography (CT).
  • The review found that AI methods, especially deep learning and convolutional neural networks, showed good diagnostic performance, with the highest accuracy in identifying the causes of LVH rather than just detecting it; more real-life validation studies and cost-effectiveness assessments are recommended.
View Article and Find Full Text PDF

Calcified amorphous tumor (CAT) is a rare, mostly incidental tumor-like cardiac lesion of unknown histogenesis. Current imaging modalities do not differentiate between CAT and other masses. As it can be a source for embolization, surgical excision of CAT is mandatory.

View Article and Find Full Text PDF

Greater than the sum of its parts: multimodality imaging in adults with congenital heart disease.

Cardiovasc Diagn Ther

December 2024

Department of Heart, Vascular & Thoracic, Division of Cardiology & Cardiovascular Medicine - Pediatric Cardiology, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.

As the population of adults with congenital heart disease (ACHD) grows, there also grows an expanded need for non-invasive surveillance methods to guide management and intervention. A multimodal imaging approach layers complementary insights from echocardiography, computed tomography (CT), magnetic resonance imaging (MRI), and other modalities into a clinician's view of patient physiology. Merely applying strategies from acquired adult cardiac disease would be inadequate and potentially misleading.

View Article and Find Full Text PDF

Introduction: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disease and screening to detect pulmonary arteriovenous malformations (PAVMs) is important to prevent complications. In adults, transthoracic contrast echocardiogram (TTCE) is used to screen PAVMs. In children, a conservative screening method seems to be sufficient to rule out major PAVMs and prevent them from PAVM-related complications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!